why choose us

First received: May 31, 2024

Clinical Trial: FET-PET/MRI Based Treatment Planning for Glioblastoma Multiforme in Post-Surgical Patients (FET-TREAT)

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Glioblastoma Multiforme

Study Type: OBSERVATIONAL


Official Title: FET-PET/MRI Based Treatment Planning for Glioblastoma Multiforme in Post-Surgical Patients (FET-TREAT)

Brief Summary: Glioblastoma multiforme (GBM) represent the most common primary brain malignancy and prognosis remains poor.The most common subtype is glioblastoma which has a 5-year survival rate of approximately 5%.Despite advances in MRI techniques, accurately determining total extent of tumor remains a challenge.The result is incomplete treatment resulting in reduced survival or overtreatment resulting in avoidable treatment related morbidity.A more accurate means of assessing tumor extent is needed to guide management to…

Read more